Capstone Holding Corp. — Director's Dealing 2013

Jan 2, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2013-01-01

Reporting Person: FELDMAN FREDRIC J (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-01-01	Stock Option (Right to Buy)	$0.17	A	10000	Acquired	2023-01-01	Common Stock (10000)	Direct